{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:10:51Z","timestamp":1790068251706,"version":"4.0.1"},"reference-count":144,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,1,9]]},"DOI":"10.18632\/aging.102677","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T16:02:09Z","timestamp":1578585729000},"page":"1011-1033","source":"Crossref","is-referenced-by-count":81,"title":["Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein"],"prefix":"10.18632","volume":"12","author":[{"given":"Wileidy","family":"Gomez","sequence":"first","affiliation":[{"name":"Laboratory of Neuroprotection and Autophagy, Center for Integrative Biology, Faculty of Science, Universidad Mayor, Santiago, Chile"},{"name":"Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular and Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Qu\u00edmicas y Farmac\u00e9uticas, Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Morales","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA"},{"name":"CIBQA, Universidad Bernardo O\u2019Higgins, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius","family":"Maracaja-Coutinho","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular and Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Qu\u00edmicas y Farmac\u00e9uticas, Universidad de Chile, Santiago, Chile"},{"name":"Centro de Modelamiento Molecular, Biof\u00edsica y Bioinform\u00e1tica (CM2B2), Facultad de Ciencias Qu\u00edmicas y Farmac\u00e9uticas, Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Parra","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular and Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Qu\u00edmicas y Farmac\u00e9uticas, Universidad de Chile, Santiago, Chile"},{"name":"Center for Exercise, Metabolism, and Cancer Studies (CEMC), Facultad de Medicina, Universidad de Chile, Santiago, Chile"},{"name":"Autophagy Research Center, Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Nassif","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroprotection and Autophagy, Center for Integrative Biology, Faculty of Science, Universidad Mayor, Santiago, Chile"},{"name":"Escuela de Biotecnolog\u00eda, Facultad de Ciencias, Universidad Mayor, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"key":"1","unstructured":"International. The state of the art of dementia research : New frontiers World Alzheimer Report 2018. 2018."},{"key":"2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"1","author":"Montine","year":"2018","journal-title":"Alzheimers Dement"},{"key":"3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.","volume":"26","author":"Pericak-Vance","year":"1993","journal-title":"Science"},{"key":"4","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/wnl.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.","volume":"4","author":"Alberts","year":"1993","journal-title":"Neurology"},{"key":"5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.","volume":"1","author":"Bu","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer\u2019s disease revisited.","volume":"1","author":"Van Broeckhoven","year":"2016","journal-title":"Alzheimers Dement"},{"key":"7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.","volume":"1","author":"Strydom","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","article-title":"Down syndrome and Alzheimer\u2019s disease: common pathways, common goals.","volume":"1","author":"Ness","year":"2015","journal-title":"Alzheimers Dement"},{"key":"9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer's disease.","volume":"4","author":"Morris","year":"1999","journal-title":"Ann Neurol"},{"key":"10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","article-title":"On the path to 2025: understanding the Alzheimer\u2019s disease continuum.","volume":"9","author":"Dubois","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00401-011-0826-y","article-title":"Alzheimer's disease is not \u201cbrain aging\u201d: neuropathological, genetic, and epidemiological human studies.","volume":"12","author":"Scheff","year":"2011","journal-title":"Acta Neuropathol"},{"key":"12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.","volume":"1","author":"Trojanowski","year":"2013","journal-title":"Lancet Neurol"},{"key":"13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cercor\/1.1.103","article-title":"The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.","volume":"1","author":"Van Hoesen","year":"1991","journal-title":"Cereb Cortex"},{"key":"14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"8","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET Imaging of Tau Deposition in the Aging Human Brain.","volume":"8","author":"Jagust","year":"2016","journal-title":"Neuron"},{"key":"16","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","article-title":"A systemic view of Alzheimer disease - insights from amyloid-\u03b2 metabolism beyond the brain.","volume":"1","author":"Wang","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"17","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease.","volume":"34","author":"Rooke","year":"1991","journal-title":"Nature"},{"key":"18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease.","volume":"2","author":"Viitanen","year":"1996","journal-title":"Nat Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory.","volume":"2","author":"Mintun","year":"2005","journal-title":"J Neurosci"},{"key":"20","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.4161\/auto.30001","article-title":"A\u03b21-42 monomers or oligomers have different effects on autophagy and apoptosis.","volume":"1","author":"Tamagno","year":"2014","journal-title":"Autophagy"},{"key":"21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15252\/emmm.201404183","article-title":"Alzheimer-associated A\u03b2 oligomers impact the central nervous system to induce peripheral metabolic deregulation.","volume":"7","author":"Bomfim","year":"2015","journal-title":"EMBO Mol Med"},{"key":"22","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/d41586-018-05719-4","article-title":"The amyloid hypothesis on trial.","volume":"55","author":"Makin","year":"2018","journal-title":"Nature"},{"key":"23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00401-016-1577-6","article-title":"Intraneuronal aggregation of the \u03b2-CTF fragment of APP (C99) induces A\u03b2-independent lysosomal-autophagic pathology.","volume":"13","author":"Checler","year":"2016","journal-title":"Acta Neuropathol"},{"key":"24","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1016\/j.biocel.2004.05.010","article-title":"Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for \u03b2-amyloid peptide over-production and localization in Alzheimer\u2019s disease.","volume":"3","author":"Nixon","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1083\/jcb.200505082","article-title":"Macroautophagy\u2014a novel Beta-amyloid peptide-generating pathway activated in Alzheimer\u2019s disease.","volume":"17","author":"Uchiyama","year":"2005","journal-title":"J Cell Biol"},{"key":"26","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1073\/pnas.0908953107","article-title":"Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition.","volume":"10","author":"Nixon","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"27","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.15252\/embj.201796797","article-title":"Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease.","volume":"3","author":"Freyberg","year":"2017","journal-title":"EMBO J"},{"key":"28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","article-title":"Intraneuronal Abeta42 accumulation in human brain.","volume":"15","author":"Relkin","year":"2000","journal-title":"Am J Pathol"},{"key":"29","first-page":"489","article-title":"Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome.","volume":"12","author":"Troncoso","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"30","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.neurobiolaging.2004.02.027","article-title":"Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.","volume":"2","author":"Nixon","year":"2004","journal-title":"Neurobiol Aging"},{"key":"31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.","volume":"2","author":"Coulter","year":"2018","journal-title":"Nat Med"},{"key":"32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41593-018-0289-8","article-title":"Tau impairs neural circuits, dominating amyloid-\u03b2 effects, in Alzheimer models in vivo.","volume":"2","author":"Hyman","year":"2019","journal-title":"Nat Neurosci"},{"key":"33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis.","volume":"7","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"34","doi-asserted-by":"publisher","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","article-title":"Trans-synaptic spread of tau pathology in vivo.","volume":"7","author":"Duff","year":"2012","journal-title":"PLoS One"},{"key":"35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ana.25060","article-title":"(18) F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.","volume":"8","author":"Grinberg","year":"2017","journal-title":"Ann Neurol"},{"key":"36","first-page":"1","article-title":"Enfermedad de Alzheimer.","author":"Sanidad","year":"2016","journal-title":"StatPearls"},{"key":"37","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/brain\/awy117","article-title":"Tau reduction in the presence of amyloid-\u03b2 prevents tau pathology and neuronal death in vivo.","volume":"14","author":"Pitstick","year":"2018","journal-title":"Brain"},{"key":"38","first-page":"125","article-title":"Down Syndrome: Current Status, Challenges and Future Perspectives.","volume":"5","author":"Kheirollahi","year":"2016","journal-title":"Int J Mol Cell Med"},{"key":"39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jpeds.2015.10.083","article-title":"Improved Survival in Down Syndrome over the Last 60 Years and the Impact of Perinatal Factors in Recent Decades.","volume":"16","author":"Leonard","year":"2016","journal-title":"J Pediatr"},{"key":"40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","article-title":"Dementia in Down syndrome: unique insights for Alzheimer disease research.","volume":"1","author":"Head","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2017.07.009","article-title":"Disturbance of redox homeostasis in Down Syndrome: role of iron dysmetabolism.","volume":"11","author":"Perluigi","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"42","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.410170310","article-title":"Occurrence of neuropathological changes and dementia of Alzheimer\u2019s disease in Down\u2019s syndrome.","volume":"1","author":"Wen","year":"1985","journal-title":"Ann Neurol"},{"key":"43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40478-018-0559-4","article-title":"The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer\u2019s disease in individuals with Down syndrome.","volume":"6","author":"Mann","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.","volume":"11","author":"Del Tredici","year":"2006","journal-title":"Acta Neuropathol"},{"key":"45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneur.1995.00540280065020","article-title":"Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down\u2019s syndrome. Quantitative regional analysis and comparison with Alzheimer\u2019s disease.","volume":"5","author":"Morrison","year":"1995","journal-title":"Arch Neurol"},{"key":"46","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1093\/nar\/gkh023","article-title":"The microRNA Registry.","volume":"3","author":"Griffiths-Jones","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"D766","DOI":"10.1093\/nar\/gky955","article-title":"GENCODE reference annotation for the human and mouse genomes.","volume":"4","author":"Bignell","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"48","doi-asserted-by":"publisher","first-page":"D754","DOI":"10.1093\/nar\/gkx1098","article-title":"Ensembl 2018.","volume":"4","author":"Haggerty","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13059-018-1405-5","article-title":"Genomic positional conservation identifies topological anchor point RNAs linked to developmental loci.","volume":"1","author":"Hemberg","year":"2018","journal-title":"Genome Biol"},{"key":"50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1352\/1944-7558-115.2.83","article-title":"Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome.","volume":"11","author":"Lopes","year":"2010","journal-title":"Am J Intellect Dev Disabil"},{"key":"51","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00335-008-9121-1","article-title":"Gene expression variation increase in trisomy 21 tissues.","volume":"1","author":"Hsieh","year":"2008","journal-title":"Mamm Genome"},{"key":"52","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.gdata.2014.07.006","article-title":"Data in brief: transcriptome analysis of induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.","volume":"2","author":"Feki","year":"2014","journal-title":"Genom Data"},{"key":"53","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature13200","article-title":"Domains of genome-wide gene expression dysregulation in Down\u2019s syndrome.","volume":"50","author":"Falconnet","year":"2014","journal-title":"Nature"},{"key":"54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrg.2016.154","article-title":"Down syndrome and the complexity of genome dosage imbalance.","volume":"1","author":"Antonarakis","year":"2017","journal-title":"Nat Rev Genet"},{"key":"55","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1056\/NEJM198906013202203","article-title":"Amyloid A4 protein and its precursor in Down\u2019s syndrome and Alzheimer\u2019s disease.","volume":"32","author":"Masters","year":"1989","journal-title":"N Engl J Med"},{"key":"56","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.neurobiolaging.2006.06.023","article-title":"Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain.","volume":"2","author":"Head","year":"2007","journal-title":"Neurobiol Aging"},{"key":"57","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbadis.2011.10.001","article-title":"Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.","volume":"182","author":"Head","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"58","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1523\/JNEUROSCI.5107-04.2005","article-title":"ets-2 promotes the activation of a mitochondrial death pathway in Down\u2019s syndrome neurons.","volume":"2","author":"Busciglio","year":"2005","journal-title":"J Neurosci"},{"key":"59","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0002-9440(10)64753-0","article-title":"Temporal accrual of complement proteins in amyloid plaques in Down\u2019s syndrome with Alzheimer\u2019s disease.","volume":"15","author":"Lemere","year":"2000","journal-title":"Am J Pathol"},{"key":"60","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1101\/lm.70104","article-title":"Search strategies used by APP transgenic mice during navigation in the Morris water maze.","volume":"1","author":"Janus","year":"2004","journal-title":"Learn Mem"},{"key":"61","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2353\/ajpath.2008.071053","article-title":"Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects.","volume":"17","author":"Nixon","year":"2008","journal-title":"Am J Pathol"},{"key":"62","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1096\/fj.201700359","article-title":"Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease.","volume":"3","author":"Nixon","year":"2017","journal-title":"FASEB J"},{"key":"63","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1093\/brain\/awy159","article-title":"Trisomy of human chromosome 21 enhances amyloid-\u03b2 deposition independently of an extra copy of APP.","volume":"14","author":"Sarell","year":"2018","journal-title":"Brain"},{"key":"64","doi-asserted-by":"publisher","first-page":"362839","DOI":"10.1155\/2012\/362839","article-title":"\u03b2-Secretases, Alzheimer\u2019s Disease, and Down Syndrome.","volume":"201","author":"Murphy","year":"2012","journal-title":"Curr Gerontol Geriatr Res"},{"key":"65","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.123431","article-title":"BACE2, a conditional \u03b2-secretase, contributes to Alzheimer's disease pathogenesis.","volume":"4","author":"Song","year":"2019","journal-title":"JCI Insight"},{"key":"66","doi-asserted-by":"publisher","first-page":"34850","DOI":"10.1074\/jbc.M707358200","article-title":"DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease.","volume":"28","author":"Song","year":"2007","journal-title":"J Biol Chem"},{"key":"67","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.nbd.2017.06.010","article-title":"Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer\u2019s disease phenotypes.","volume":"10","author":"Mart\u00ednez-Cu\u00e9","year":"2017","journal-title":"Neurobiol Dis"},{"key":"68","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/acel.12648","article-title":"Dyrk1 inhibition improves Alzheimer\u2019s disease-like pathology.","volume":"1","author":"Oddo","year":"2017","journal-title":"Aging Cell"},{"key":"69","doi-asserted-by":"publisher","first-page":"13161","DOI":"10.1523\/jneurosci.3974-07.2007","article-title":"The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling.","volume":"2","author":"Rothermel","year":"2007","journal-title":"J Neurosci"},{"key":"70","doi-asserted-by":"publisher","first-page":"16930","DOI":"10.1523\/JNEUROSCI.3513-12.2013","article-title":"Regulator of calcineurin 1 modulates expression of innate anxiety and anxiogenic responses to selective serotonin reuptake inhibitor treatment.","volume":"3","author":"Klann","year":"2013","journal-title":"J Neurosci"},{"key":"71","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.arcmed.2012.10.012","article-title":"Role of tau protein in neuronal damage in Alzheimer\u2019s disease and Down syndrome.","volume":"4","author":"Caviedes","year":"2012","journal-title":"Arch Med Res"},{"key":"72","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.neurobiolaging.2006.03.008","article-title":"Oxidative stress: a bridge between Down\u2019s syndrome and Alzheimer\u2019s disease.","volume":"2","author":"K\u00e1lm\u00e1n","year":"2007","journal-title":"Neurobiol Aging"},{"key":"73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/S0033291708003334","article-title":"The relationship of dementia prevalence in older adults with intellectual disability (ID) to age and severity of ID.","volume":"3","author":"Livingston","year":"2009","journal-title":"Psychol Med"},{"key":"74","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JAD-2012-120073","article-title":"Oxidative stress and memory decline in adults with Down syndrome: longitudinal study.","volume":"3","author":"Team","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"75","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/hmg\/6.11.1951","article-title":"Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice.","volume":"6","author":"Hsiao","year":"1997","journal-title":"Hum Mol Genet"},{"key":"76","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","article-title":"Hydrogen peroxide mediates amyloid beta protein toxicity.","volume":"7","author":"Schubert","year":"1994","journal-title":"Cell"},{"key":"77","doi-asserted-by":"publisher","first-page":"44557","DOI":"10.1074\/jbc.M111.279208","article-title":"SOD1 (copper\/zinc superoxide dismutase) deficiency drives amyloid \u03b2 protein oligomerization and memory loss in mouse model of Alzheimer disease.","volume":"28","author":"Shimizu","year":"2011","journal-title":"J Biol Chem"},{"key":"78","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/S0024-3205(02)01538-2","article-title":"Evidence for increased mitochondrial superoxide production in Down syndrome.","volume":"7","author":"Trush","year":"2002","journal-title":"Life Sci"},{"key":"79","doi-asserted-by":"publisher","first-page":"10169","DOI":"10.1074\/jbc.271.17.10169","article-title":"Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells.","volume":"27","author":"Piatigorsky","year":"1996","journal-title":"J Biol Chem"},{"key":"80","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1471-4159.2004.02895.x","article-title":"Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways.","volume":"9","author":"Tabaton","year":"2005","journal-title":"J Neurochem"},{"key":"81","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.bbadis.2013.09.015","article-title":"Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.","volume":"184","author":"Butterfield","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"82","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/PL00000661","article-title":"Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer\u2019s disease and Down syndrome.","volume":"5","author":"Lubec","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"83","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10522-006-9002-5","article-title":"Multiple evidence for an early age pro-oxidant state in Down Syndrome patients.","volume":"7","author":"Pagano","year":"2006","journal-title":"Biogerontology"},{"key":"84","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/jci200318182","article-title":"Oxidative stress, cell cycle, and neurodegeneration.","volume":"11","author":"Ackerman","year":"2003","journal-title":"J Clin Invest"},{"key":"85","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","article-title":"Adaptive downregulation of mitochondrial function in down syndrome.","volume":"1","author":"Busciglio","year":"2013","journal-title":"Cell Metab"},{"key":"86","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1161\/CIRCRESAHA.117.311522","article-title":"Down Syndrome Critical Region 1 Gene,, Helps Maintain a More Fused Mitochondrial Network.","volume":"12","author":"Rothermel","year":"2018","journal-title":"Circ Res"},{"key":"87","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41556-018-0092-5","article-title":"A brief history of autophagy from cell biology to physiology and disease.","volume":"2","author":"Mizushima","year":"2018","journal-title":"Nat Cell Biol"},{"key":"88","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","article-title":"Mechanism and medical implications of mammalian autophagy.","volume":"1","author":"Elazar","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"89","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1196\/annals.1396.020","article-title":"The role of autophagy in aging: its essential part in the anti-aging mechanism of caloric restriction.","volume":"111","author":"Gori","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"90","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","article-title":"Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study.","volume":"6","author":"Cuervo","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"91","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1042\/BST20130201","article-title":"Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime.","volume":"4","author":"Nixon","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"92","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","article-title":"Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations.","volume":"14","author":"Nixon","year":"2010","journal-title":"Cell"},{"key":"93","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1073\/pnas.1009485107","article-title":"Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer\u2019s disease.","volume":"10","author":"Yuan","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"94","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1523\/JNEUROSCI.0578-19.2019","article-title":"Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-\u03b2CTF (C99).","volume":"3","author":"Nixon","year":"2019","journal-title":"J Neurosci"},{"key":"95","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.freeradbiomed.2017.08.009","article-title":"mTOR in Down syndrome: role in A\u00df and tau neuropathology and transition to Alzheimer disease-like dementia.","volume":"11","author":"Butterfield","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"96","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-018-0133-9","article-title":"Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome.","volume":"7","author":"Di Domenico","year":"2018","journal-title":"Transl Neurodegener"},{"key":"97","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.","volume":"28","author":"Oddo","year":"2010","journal-title":"J Biol Chem"},{"key":"98","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41419-019-1752-5","article-title":"mTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy.","volume":"1","author":"Nixon","year":"2019","journal-title":"Cell Death Dis"},{"key":"99","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/bs.ircmb.2017.07.002","article-title":"New Insights Into Autophagy Dysfunction Related to Amyloid Beta Toxicity and Neuropathology in Alzheimer's Disease.","volume":"33","author":"Loos","year":"2018","journal-title":"Int Rev Cell Mol Biol"},{"key":"100","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","article-title":"Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.","volume":"15","author":"Nixon","year":"2000","journal-title":"Am J Pathol"},{"key":"101","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1093\/hmg\/dds142","article-title":"Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes.","volume":"2","author":"Antonarakis","year":"2012","journal-title":"Hum Mol Genet"},{"key":"102","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0014-5793(97)01451-8","article-title":"Synaptojanin 1: localization on coated endocytic intermediates in nerve terminals and interaction of its 170 kDa isoform with Eps15.","volume":"41","author":"De Camilli","year":"1997","journal-title":"FEBS Lett"},{"key":"103","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0092-8674(00)81649-9","article-title":"Essential role of phosphoinositide metabolism in synaptic vesicle recycling.","volume":"9","author":"De Camilli","year":"1999","journal-title":"Cell"},{"key":"104","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fncel.2018.00189","article-title":"RCAN1 Knockdown Reverts Defects in the Number of Calcium-Induced Exocytotic Events in a Cellular Model of Down Syndrome.","volume":"1","author":"C\u00e1rdenas","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"105","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1089\/ars.2016.6686","article-title":"Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology.","volume":"2","author":"Perluigi","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"106","doi-asserted-by":"publisher","first-page":"14088","DOI":"10.1074\/jbc.M111.305342","article-title":"Chronic expression of RCAN1-1L protein induces mitochondrial autophagy and metabolic shift from oxidative phosphorylation to glycolysis in neuronal cells.","volume":"28","author":"Davies","year":"2012","journal-title":"J Biol Chem"},{"key":"107","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/brain\/awq341","article-title":"Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer\u2019s disease ameliorates amyloid pathologies and memory deficits.","volume":"13","author":"Yang","year":"2011","journal-title":"Brain"},{"key":"108","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1093\/brain\/awu278","article-title":"Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits.","volume":"13","author":"Nixon","year":"2014","journal-title":"Brain"},{"key":"109","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1016\/j.celrep.2018.05.098","article-title":"Inhibition of Lysosome Membrane Recycling Causes Accumulation of Gangliosides that Contribute to Neurodegeneration.","volume":"2","author":"Darios","year":"2018","journal-title":"Cell Rep"},{"key":"110","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bbr.2010.10.023","article-title":"The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome.","volume":"21","author":"Herault","year":"2011","journal-title":"Behav Brain Res"},{"key":"111","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.","volume":"9","author":"Apolipoprotein","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"112","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration.","volume":"14","author":"Gage","year":"2010","journal-title":"Cell"},{"key":"113","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fncel.2018.00072","article-title":"An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.","volume":"1","author":"Giusti","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"114","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1742-2094-10-84","article-title":"Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis.","volume":"1","author":"Griffin","year":"2013","journal-title":"J Neuroinflammation"},{"key":"115","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/42257","article-title":"Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.","volume":"38","author":"Harmon","year":"1997","journal-title":"Nature"},{"key":"116","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1093\/brain\/awt171","article-title":"Dissecting phenotypic traits linked to human resilience to Alzheimer\u2019s pathology.","volume":"13","author":"Lowe","year":"2013","journal-title":"Brain"},{"key":"117","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.12.020","article-title":"Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis.","volume":"6","author":"Hetz","year":"2018","journal-title":"Neurobiol Aging"},{"key":"118","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1086\/519979","article-title":"Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes.","volume":"8","author":"Antonarakis","year":"2007","journal-title":"Am J Hum Genet"},{"key":"119","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.biocel.2017.09.017","article-title":"Dysfunctions of mitochondria in close association with strong perturbation of long noncoding RNAs expression in down syndrome.","volume":"9","author":"Yan","year":"2017","journal-title":"Int J Biochem Cell Biol"},{"key":"120","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40246-018-0133-y","article-title":"Identify Down syndrome transcriptome associations using integrative analysis of microarray database and correlation-interaction network.","volume":"1","author":"Chen","year":"2018","journal-title":"Hum Genomics"},{"key":"121","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nm1784","article-title":"Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.","volume":"1","author":"Wahlestedt","year":"2008","journal-title":"Nat Med"},{"key":"122","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s12035-012-8359-5","article-title":"Non-coding RNAs in Alzheimer's disease.","volume":"4","author":"Tan","year":"2013","journal-title":"Mol Neurobiol"},{"key":"123","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1016\/j.neurobiolaging.2015.07.015","article-title":"Identification of Alzheimer\u2019s disease-associated long noncoding RNAs.","volume":"3","author":"Xu","year":"2015","journal-title":"Neurobiol Aging"},{"key":"124","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2147\/CIA.S107037","article-title":"Long noncoding RNAs and Alzheimer's disease.","volume":"1","author":"Chen","year":"2016","journal-title":"Clin Interv Aging"},{"key":"125","doi-asserted-by":"publisher","first-page":"30105","DOI":"10.3390\/ijms161226223","article-title":"MicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer\u2019s Disease (AD)-Novel and Unique Pathological Features.","volume":"1","author":"Lukiw","year":"2015","journal-title":"Int J Mol Sci"},{"key":"126","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1007\/s12035-016-9793-6","article-title":"The Role of Long Noncoding RNAs in Neurodegenerative Diseases.","volume":"5","author":"Zhuo","year":"2017","journal-title":"Mol Neurobiol"},{"key":"127","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2174\/1567205014666170706112701","article-title":"Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.","volume":"1","author":"Arena","year":"2017","journal-title":"Curr Alzheimer Res"},{"key":"128","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fncel.2014.00054","article-title":"Non-coding RNAs in chromatin disease involving neurological defects.","volume":"8","author":"Matarazzo","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"129","doi-asserted-by":"publisher","first-page":"e1001212","DOI":"10.1371\/journal.pgen.1001212","article-title":"Altered DNA methylation in leukocytes with trisomy 21.","volume":"6","author":"Schork","year":"2010","journal-title":"PLoS Genet"},{"key":"130","doi-asserted-by":"publisher","first-page":"82","DOI":"10.18632\/aging.100715","article-title":"Identification of a DNA methylation signature in blood cells from persons with Down Syndrome.","volume":"7","author":"Del Rio","year":"2015","journal-title":"Aging (Albany NY)"},{"key":"131","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13059-015-0827-6","article-title":"Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models.","volume":"1","author":"Liu","year":"2015","journal-title":"Genome Biol"},{"key":"132","doi-asserted-by":"publisher","first-page":"e0135555","DOI":"10.1371\/journal.pone.0135555","article-title":"DNA-Methylation Patterns in Trisomy 21 Using Cells from Monozygotic Twins.","volume":"1","author":"Feki","year":"2015","journal-title":"PLoS One"},{"key":"133","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/pd.4256","article-title":"Placental methylation markers in normal and trisomy 21 tissues.","volume":"3","author":"Ye","year":"2014","journal-title":"Prenat Diagn"},{"key":"134","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jmoldx.2015.12.002","article-title":"Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.","volume":"1","author":"Ryu","year":"2016","journal-title":"J Mol Diagn"},{"key":"135","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13148-015-0142-9","article-title":"Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer's disease.","volume":"7","author":"Garcia-Osta","year":"2015","journal-title":"Clin Epigenetics"},{"key":"136","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.clinbiochem.2006.11.021","article-title":"Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease.","volume":"4","author":"Chung","year":"2007","journal-title":"Clin Biochem"},{"key":"137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/npjscilearn.2016.14","article-title":"Cognitive neuroepigenetics: the next evolution in our understanding of the molecular mechanisms underlying learning and memory?","volume":"1","author":"Bredy","year":"2016","journal-title":"NPJ Sci Learn"},{"key":"138","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease.","volume":"53","author":"Arastu","year":"2016","journal-title":"Nature"},{"key":"139","unstructured":"Biogen. Biogen Q3 2019 Earnings Presentation. investors.biogen. com http:\/\/investors.biogen.com\/static-files\/40565136-b61f-4473-9e58-9be769bbac6c."},{"key":"140","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0295-9","article-title":"Questions EMERGE as Biogen claims aducanumab turnaround.","author":"Liu","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"141","doi-asserted-by":"publisher","first-page":"693","DOI":"10.4103\/1673-5374.182680","article-title":"Alzheimer's disease: the silver tsunami of the 21(st) century.","volume":"1","author":"Singh","year":"2016","journal-title":"Neural Regen Res"},{"key":"142","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2017.08.014","article-title":"Mitochondria as pharmacological targets in Down syndrome.","volume":"11","author":"Vacca","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"143","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neubiorev.2014.05.004","article-title":"Epigenetics: the neglected key to minimize learning and memory deficits in Down syndrome.","volume":"4","author":"Rots","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"144","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2174\/1570159X14666160630210422","article-title":"Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.","volume":"1","author":"Baril","year":"2017","journal-title":"Curr Neuropharmacol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T15:47:05Z","timestamp":1599061625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,15]]}},"alternative-id":["102677","31918411"],"URL":"https:\/\/doi.org\/10.18632\/aging.102677","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]}}}